New data from clinical practice again confirmed the high efficacy and a favorable safety profile of the drug Xarelto® in patients with atrial fibrillation (Press release of the company Bayer)
.
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2016-09-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Online Access: | https://www.rpcardio.online/jour/article/view/1319 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839641288781070336 |
|---|---|
| author | Article Editorial |
| author_facet | Article Editorial |
| author_sort | Article Editorial |
| collection | DOAJ |
| description | . |
| format | Article |
| id | doaj-art-a2de98d0e48a4bdb99c9a0d5f15e5b0a |
| institution | Matheson Library |
| issn | 1819-6446 2225-3653 |
| language | English |
| publishDate | 2016-09-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj-art-a2de98d0e48a4bdb99c9a0d5f15e5b0a2025-07-03T07:28:32ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532016-09-011244874881252New data from clinical practice again confirmed the high efficacy and a favorable safety profile of the drug Xarelto® in patients with atrial fibrillation (Press release of the company Bayer)Article Editorial.https://www.rpcardio.online/jour/article/view/1319 |
| spellingShingle | Article Editorial New data from clinical practice again confirmed the high efficacy and a favorable safety profile of the drug Xarelto® in patients with atrial fibrillation (Press release of the company Bayer) Рациональная фармакотерапия в кардиологии |
| title | New data from clinical practice again confirmed the high efficacy and a favorable safety profile of the drug Xarelto® in patients with atrial fibrillation (Press release of the company Bayer) |
| title_full | New data from clinical practice again confirmed the high efficacy and a favorable safety profile of the drug Xarelto® in patients with atrial fibrillation (Press release of the company Bayer) |
| title_fullStr | New data from clinical practice again confirmed the high efficacy and a favorable safety profile of the drug Xarelto® in patients with atrial fibrillation (Press release of the company Bayer) |
| title_full_unstemmed | New data from clinical practice again confirmed the high efficacy and a favorable safety profile of the drug Xarelto® in patients with atrial fibrillation (Press release of the company Bayer) |
| title_short | New data from clinical practice again confirmed the high efficacy and a favorable safety profile of the drug Xarelto® in patients with atrial fibrillation (Press release of the company Bayer) |
| title_sort | new data from clinical practice again confirmed the high efficacy and a favorable safety profile of the drug xarelto r in patients with atrial fibrillation press release of the company bayer |
| url | https://www.rpcardio.online/jour/article/view/1319 |
| work_keys_str_mv | AT articleeditorial newdatafromclinicalpracticeagainconfirmedthehighefficacyandafavorablesafetyprofileofthedrugxareltoinpatientswithatrialfibrillationpressreleaseofthecompanybayer |